Epstein-Barr virus downregulates the α7 nicotinic acetylcholine receptor of CD8

Lvyan Tao1, Tiesong Zhang1, Yuantao Zhou1

  • 1Yunnan Medical Center for Pediatric Diseases, Yunnan Institute of Pediatrics, Kunming Children's Hospital, Kunming 650228, Yunnan, China; Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Province Clinical Research Center for Children's Health and Disease, Kunming 650228, Yunnan, China.

PubMed

Insights

Epstein-Barr virus (EBV) infection status impacts coronary artery lesions (CALs) in Kawasaki disease (KD). Acute EBV infection without detectable DNA showed higher CALs than acute EBV infection with DNA, with latent EBV infection showing the highest CALs.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • Kawasaki disease (KD) is a critical pediatric vasculitis linked to immune dysregulation and pathogens like Epstein-Barr virus (EBV).
  • Coronary artery lesions (CALs) in KD can lead to severe cardiac complications, but the interplay between pathogens, immune responses, and CALs remains unclear, especially with EBV co-infection.

Purpose of the Study:

  • To investigate the relationship between EBV infection status and the incidence of CALs in pediatric KD patients.
  • To analyze immunological differences and regulatory mechanisms associated with varying EBV infection states in KD.

Main Methods:

  • Studied pathogen carriage and clinical data in 281 KD patients.
  • Analyzed immunological profiles (IL-6, B cells, CD8+ T cells, α7nAChR, PI3K/AKT/mTOR, NF-κB) in relation to CALs and EBV infection status (acute EBV-DNA positive, acute EBV-DNA negative, latent EBV).

Main Results:

  • EBV was the most prevalent pathogen in KD patients.
  • CAL incidence was 0% in acute EBV-DNA (+) group, 27.27% in acute EBV-DNA (-) group, and 41.67% in latent EBV group.
  • Patients with acute EBV-DNA (-) and latent EBV infections were younger, had higher IL-6 and B cells, lower CD8+ T cells, downregulated α7nAChR and PI3K/AKT/mTOR, and activated NF-κB compared to the acute EBV-DNA (+) group.

Conclusions:

  • Different EBV infection statuses correlate with varying CAL incidence in KD.
  • Downregulation of α7nAChR and PI3K/AKT/mTOR, alongside NF-κB and IL-6 activation, may contribute to CAL development in EBV-infected KD patients.
Abstract